Robert Martell

Robert E.
Martell was the founder of Epi-Cure Pharmaceuticals, Inc., founded in 2016, where the titles held included President, Secretary, Treasurer & Director from 2016 to 2018.
Current jobs include Chief Scientific Officer at Curis, Inc. since 2011, Member at American Society of Clinical Oncology, Inc., Member at American Association for Cancer Research, and Professor at Tufts University School of Medicine.
Former jobs include Independent Director at Indaptus Therapeutics, Inc. from 2023 to 2025; Chief Medical Officer at Tesaro, Inc. from 2012 to 2015; Chief Medical Officer & Vice President at Mirati Therapeutics, Inc. from 2005 to 2009; Associate Professor at Tufts Medical Center, Inc. from 2009 to 2012; Associate Chief-Hematology & Oncology Division at Tufts Medical Center, Inc.; Director-Oncology Global Clinical Research at Bristol Myers Squibb Co. from 2002 to 2005; Deputy Director-Pharmaceutical Division at Bayer Corp.
from 2000 to 2002; Deputy Director-Medical Science Unit at Bayer Pharmaceuticals Corp.; Director-Neely Center at Clinical Cancer Research; Assistant Clinical Professor at Yale School of Medicine from 2001 to 2005; and Assistant Professor at Duke University Medical Center from 1998 to 2000.
Education includes a doctorate from Wayne State University (Michigan), an undergraduate degree from Kalamazoo College, and a doctorate from the University of Michigan.